Description
This report analyzes the world markets for human antiviral medications, focusing on the current market for and the development of drugs that are used to directly combat and treat viruses viral infections. For the purposes of this report, antivirals are drugs used to directly treat viral infection after it occurs. The report does not discuss products for the prevention of viral infection—that is, adult or pediatric vaccinations—and does not discuss other diseases, such as cancer or heart disease, that may be caused by a virus.
Market analysis is provided for various geographic regions and for various viral groups to 2006. The report profiles several companies involved in marketing or developing antiviral products, including Boehrinnger Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Pfizer, and Merck, among others. The report generally reviews the nature and direction of research, as well as the markets for currently available drugs.
Market forecasts are based on an examination of current market conditions and on investigations into the development of new products by key companies. This information also is weighted with projected timing and the probability of receiving FDA approval to market products. The information presented in this report is the result of data gathered from interviews with company executives and other industry stakeholders. Company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press, provide supporting information.
Don’t forget to check out Volumes I and II of this exciting series! Purchase two volumes and save 10% or purchase the entire series and save 20%!
Volume I: The World Market for Antifungal Medications
Volume II: The World Market for Antibacterial Medications
The World Market for Anti-infectives Series – Volumes I-III
